A case of reinitiation of modified electroconvulsive therapy 2 weeks after modified electroconvulsive therapy‐induced Takotsubo cardiomyopathy in a male patient with major depressive disorder

Documenti analoghi

• Blood‐based circRNA / miRNA biomarkers for modified electroconvulsive therapy efficacy and memory impairment in major depressive disorder
  di: Shugui Gao, et al.
  Pubblicazione: (2025)
• A case report of ineffective electroconvulsive therapy for chronic pain
  di: Takashi Fukao, et al.
  Pubblicazione: (2025)
• Commentary on the article titled “Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvulsive therapy” by Xu et al.
  di: Alexander A. Yakovlev
  Pubblicazione: (2024)
• Safety of electroconvulsive therapy in the context of physiological and medical complexity: A state‐of‐the art review
  di: Alby Elias, et al.
  Pubblicazione: (2025)
• Cardiogenic cerebral infarction after Takotsubo cardiomyopathy in a patient with catatonia: A case report
  di: Masaki Fujiwara, et al.
  Pubblicazione: (2026)